Global Cancer Diagnostics Market is Expected to Register a Healthy CAGR in the Forecast Period of 2019 to 2026

Access Full Report at

Global Cancer Diagnostics Market

Cancer diagnostics is the process of identifying certain proteins, and symptoms associated with the presence of cancerous cells in patients. These symptoms then result in the physicians conducting biopsies on the suspected cancerous cells which results in assured diagnosis process. The overall diagnosis of this process involves the usage of specifically designed technologies and devices.

Segmentation: Global Cancer Diagnostics Market

Global cancer diagnostics market is segmented on the basis of:

  • Technology – Instrument Based (Biopsies, Liquid Biopsy), Platform-Based, Tumor Biomarker Tests
  • Application – Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Pancreatic Cancer, Ovarian Cancer, Others
  • End-User – Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Others
  • Geography – North America, South America, Europe, Asia-Pacific, Middle East and Africa

Key Market Competitors: Global Cancer Diagnostics Market

Few of the major competitors c           urrently working in the global cancer diagnostics market are Abbott; Agilent Technologies, Inc.; BD; bioMérieux SA; NeoGenomics Laboratories, Inc.; Telerad Tech; F. Hoffmann-La Roche Ltd; GENERAL ELECTRIC COMPANY; Hologic Inc.; Illumina, Inc.; QIAGEN; BioGenex; Siemens Healthcare GmbH; BioNTech Diagnostics GmbH; Thermo Fisher Scientific Inc. and Koninklijke Philips N.V.

Rising levels of geriatric population

The rate at which the geriatric population is rising is alarming, and this trend can be seen throughout the different regions of the world. This category is generally prone to a number of chronic diseases, life-threating disorders and majorly cancer. This population group requires extra care, treatment and solutions to restrict the time it takes to treat and heal them.

This factor is one of the major drivers of the cancer diagnostics market as they can accurately identify at which stage is cancer present in the patient, whether it has metastasized or not. It can also help decide the next course of action at an early stage so that the best treatment possible can be provided to the patients.

Browse Related Reports:

Global Point-Of-care diagnostics Market By Product(Glucose, Cardio metabolic, Infectious Disease, Influenza, HIV, Hepatitis C, Sexually Transmitted Disease (STD), Healthcare-Associated Infection (HAI) , Respiratory Infection , Tropical Disease, Other Infectious Disease, Coagulation, PT/INR Activated Clotting Time (ACT/APTT), Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, Other POC Products), Platform (Lateral Flow Assays (Immunochromatography Tests), Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays)  Prescription (Prescription-Based Testing, OTC Testing),  End User (Professional Diagnostic Centers (Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Settings, Hospitals/Critical Care Centers, Home Care, Research Laboratories, Other End Users), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Global Tissue Diagnostics Market, By Product (Consumables, Instruments), By Technology (Immunohistochemistry, In Situ Hybridization, Digital Pathology & Workflow Management, Special Staining), By Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, Other Diseases), End-User (Hospitals, Pharmaceutical Companies, Research Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends & Forecast to 2026

Global In Vitro Diagnostics/IVD Market By Technology (Immunochemistry/Immunoassays, Clinical Chemistry, Molecular Diagnostics, Clinical Microbiology, Hematology, Coagulation and Hemostasis), By Product & Service (Reagents & Kits, Instruments, Data Management Software, Services), By Application (Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing or Pharmacogenomics, HIV/AIDS), By End-User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes), By Geography  – Industry Trends and Forecast to 2024